Melanocortin Research Peptides: Class Overview and Members

Key takeaways

• Melanocortin peptides are synthetic analogs of α-MSH that act at the melanocortin receptor family (MC1R–MC5R); MC2R is the ACTH-selective receptor and is generally not the target of these analogs.
• Melanotan I (afamelanotide) is a linear 13-residue α-MSH analog; Melanotan II is a cyclic lactam heptapeptide analog (~1024 Da); PT-141 (bremelanotide) is a cyclic heptapeptide (~1025 Da) closely related to Melanotan II.
• The defining structural variable across the class is cyclization — a linear backbone (Melanotan I) versus a constrained cyclic lactam ring (Melanotan II, PT-141) that changes conformation and receptor-binding geometry.
• All three share the conserved His-Phe-Arg-Trp message sequence derived from α-MSH, with D-Phe and Nle substitutions that increase stability over the native hormone.
• Ascend Bio Labs publishes a per-batch Certificate of Analysis (HPLC purity + LC-MS identity, third-party, US-domestic) for melanocortin compounds, so the molecular weight and identity you read here can be confirmed against the exact vial.

The melanocortin research peptides are a tightly related family of synthetic analogs built on the same biological template: α-melanocyte-stimulating hormone (α-MSH). Vendors usually list them one product at a time — PT-141 here, Melanotan I and II there — which obscures how closely the three are related at the level of sequence and three-dimensional shape. This overview groups them by what actually distinguishes them: backbone length, cyclization, and which melanocortin receptors the structure was designed to engage.

Everything below is research-use-only structural context. The goal is to describe what these molecules ARE — their sequences, molecular weights, ring chemistry, and receptor-class targets — not anything they might do in a body. For deeper single-compound breakdowns, this post links out to dedicated structure guides for PT-141 and the Melanotan I vs Melanotan II comparison.

What defines the melanocortin peptide class

The melanocortin system is built around five G-protein-coupled receptors, designated MC1R through MC5R, and a set of endogenous peptide ligands derived from the precursor protein proopiomelanocortin (POMC). α-MSH is one of those native ligands. The research peptides in this class are synthetic analogs of α-MSH — molecules engineered to retain the parts of the hormone that interact with melanocortin receptors while modifying the parts that make the native peptide short-lived.

A practical way to read the class is by receptor target. MC1R is most associated with melanocyte signaling; MC3R and MC4R are central-nervous-system receptors; MC5R is broadly distributed; and MC2R is the odd one out — it is the ACTH-selective receptor and is generally NOT engaged by these α-MSH analogs. When a compound is described as a 'non-selective melanocortin agonist,' it typically means activity across MC1, MC3, MC4, and MC5, sparing MC2.

The single conserved structural motif that ties the class together is the core His-Phe-Arg-Trp 'message sequence' carried over from α-MSH. Every member discussed here preserves a version of that tetrapeptide; what changes between members is the backbone around it — linear versus cyclic — and the stabilizing substitutions.

• Receptor family: MC1R, MC3R, MC4R, MC5R (MC2R is ACTH-selective and generally not a target)
• Shared parent hormone: α-melanocyte-stimulating hormone (α-MSH), a POMC-derived peptide
• Conserved motif: the His-Phe-Arg-Trp message sequence
• Common stabilizing substitutions: norleucine (Nle) and D-phenylalanine (D-Phe) in place of native residues

Melanotan I (afamelanotide): the linear analog

Melanotan I — known as afamelanotide — is the most structurally conservative member of the group. It is a linear analog of α-MSH that keeps the full 13-residue backbone of the native hormone, with two key modifications relative to wild-type α-MSH: a norleucine (Nle) substitution at position 4 and a D-phenylalanine (D-Phe) at position 7. These substitutions make the synthetic peptide more resistant to enzymatic degradation than the native sequence while preserving the message region.

Because it retains the full linear chain, Melanotan I is the largest of the three by molecular weight, on the order of ~1646 Da. Structurally it is the closest of the group to natural α-MSH — it is essentially a stabilized version of the parent hormone rather than a redesigned, ring-constrained molecule. That linearity is exactly the property the next two members were engineered away from.

• Class: linear α-MSH analog
• Backbone: 13 amino acid residues (full α-MSH length)
• Key substitutions: [Nle4, D-Phe7]-α-MSH
• Approximate molecular weight: ~1646 Da
• Defining trait: closest structural relative to native α-MSH

Melanotan II: the cyclic lactam analog

Melanotan II is where the class takes its structural turn. Rather than a linear chain, it is a cyclic lactam analog of α-MSH — a much shorter heptapeptide whose ring is formed by a covalent bond between the side chains of an aspartic acid and a lysine residue. In synthesis terms, the ε-amino group of lysine and the γ-carboxyl group of aspartic acid are joined (lactamization), closing the peptide into a ring that is then capped with N-acetyl-norleucine.

Its sequence is written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, molecular formula C50H69N15O9, with a molecular weight of approximately 1024 Da. The cyclization is the point: locking the backbone into a constrained ring reduces conformational flexibility and presents the His-D-Phe-Arg-Trp message in a fixed three-dimensional geometry. Unlike the more receptor-specific PT-141, Melanotan II is generally described as a broad, non-selective melanocortin agonist across the MC1/MC3/MC4/MC5 receptors.

For a side-by-side of why the linear-versus-cyclic distinction matters between the two Melanotans, see Melanotan I vs Melanotan II: Structural Differences Explained.

• Class: cyclic lactam α-MSH analog (heptapeptide)
• Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
• Molecular formula: C50H69N15O9
• Approximate molecular weight: ~1024 Da
• Defining trait: side-chain lactam ring; broad non-selective MCR profile

PT-141 (bremelanotide): the cyclic heptapeptide relative of MT-II

PT-141 — bremelanotide — is the closest structural relative of Melanotan II, and the relationship is direct: it is essentially the deaminated, carboxyl-terminal variant of the same cyclic scaffold. Its sequence is written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, a cyclic heptapeptide with molecular formula C50H68N14O10 and a molecular weight of approximately 1025 Da. Compared with Melanotan II, the terminal amide (-NH2) is replaced by a carboxylic acid (-OH), which accounts for the small difference in formula and mass.

Like Melanotan II, PT-141 adopts a constrained cyclic conformation rather than a free linear chain, and it carries the same conserved His-D-Phe-Arg-Trp message. The literature describes it as a melanocortin receptor agonist with activity across the family but particular affinity at the central MC3R and MC4R, distinguishing its receptor profile somewhat from the broader Melanotan II.

For the full single-compound structural breakdown, see What Is PT-141 (Bremelanotide)? Melanocortin Peptide Structure.

• Class: cyclic heptapeptide α-MSH analog
• Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
• Molecular formula: C50H68N14O10
• Approximate molecular weight: ~1025 Da
• Relationship to MT-II: carboxyl (-OH) terminus instead of amide (-NH2); particular affinity at MC3R/MC4R

The class at a glance: structure-by-structure comparison

The three members are best understood relative to one another. The table consolidates the structural facts above so the linear-versus-cyclic axis and the small terminal-chemistry difference between Melanotan II and PT-141 are visible side by side. Molecular weights are approximate and rounded; always confirm identity against the batch-specific COA for the exact material you are characterizing.

Handling, reconstitution, and storage (research context)

Melanocortin peptides ship as lyophilized (freeze-dried) powder and are reconstituted in the laboratory for in-vitro work. The standard reconstitution diluent for this class is bacteriostatic water; sterile water is sometimes used where the bacteriostatic agent is not wanted. The lyophilized powder is generally stored cold and protected from light, with reconstituted solution kept refrigerated and used within a limited window, consistent with the general handling guidance for short synthetic peptides. Always defer to the storage instructions on the specific product's COA and label.

Because these are temperature- and light-sensitive materials, transit handling matters. Ascend Bio Labs ships melanocortin compounds from US-domestic stock with insulated, tracked shipping, which reduces the time the material spends outside controlled conditions relative to long overseas transshipment routes.

• Form: lyophilized powder, reconstituted in the lab before use
• Typical diluent: bacteriostatic water (or sterile water where preferred)
• Storage: lyophilized cold and protected from light; reconstituted solution refrigerated
• Always follow the storage window stated on the product's COA and label

Verifying identity and purity before you characterize a melanocortin peptide

For a class defined by small structural differences — a terminal -NH2 versus -OH, a linear chain versus a lactam ring — identity verification is not optional. The molecular weights above are close enough between Melanotan II and PT-141 that the only reliable way to confirm which compound is in a vial is the analytical data, not the label. That is where a real, batch-linked Certificate of Analysis earns its place.

Ascend Bio Labs publishes a per-batch COA for each melanocortin compound: HPLC for purity and LC-MS for molecular identity, run by an independent third-party lab, with a unique batch ID printed on each vial that links to its own certificate. Because synthesis, testing, storage, and shipping are US-domestic, the chain from production to your bench is traceable. The takeaway for the class is simple: read the structure to know what you are looking for, then confirm the LC-MS mass and HPLC purity against the batch COA for the exact vial in front of you.

• HPLC purity + LC-MS identity on every batch (third-party)
• Unique batch ID on each vial resolves to its own public COA
• US-domestic synthesis, testing, storage, and shipping
• Confirm the LC-MS mass against the expected molecular weight for the specific analog

Related research notes

• What Is PT-141 (Bremelanotide)? Melanocortin Peptide Structure
• Melanotan I vs Melanotan II: Structural Differences Explained
• GH Secretagogue Research Peptides: A Structural Overview
• What Is MOTS-c? Mitochondrial-Derived Peptide Structure